Laboratory Corporation of America Holdings (NYSE:LH) went up by 3.85% from its latest closing price when compared to the 1-year high value of $188.20 and move up 3.35%, while LH stocks collected +5.90% of gains with the last five trading sessions. Press Release reported 16 hours ago that LabCorp Announces 2019 Fourth Quarter and Full Year Results and Provides 2020 Guidance

Laboratory Corporation of America Holdings (NYSE:LH) Worth an Investment?

Laboratory Corporation of America Holdings (NYSE: LH) scored price to earnings ratio above its average ratio, recording 24.66 times of increase in earnings at the present.

LH Market Performance

LH stocks went up by 5.90% for the week, with the monthly jump of 7.95% and a quarterly performance of 17.22%, while its annual performance rate touched 32.30%. The simple moving average for the period of the last 20 days is 7.87% for LH stocks with the simple moving average of 14.76% for the last 200 days.

Analysts’ Opinion on Laboratory Corporation of America Holdings (NYSE:LH)

Many brokerage firms have already submitted their reports for LH stocks, with Wells Fargo repeating the rating for LH shares by setting it to “Overweight”. The predicted price for LH socks in the upcoming period according to Wells Fargo is $210 based on the research report published on January 8, 2020.

BofA/Merrill, on the other hand, stated in their research note that they expect to see LH stock at the price of $210. The rating they have provided for LH stocks is “Neutral” according to the report published on July 16, 2019.

Deutsche Bank gave “ Buy” rating to LH stocks, setting the target price at $220 in the report published on June 21, 2019.

LH Stocks 11.66% Far from 50 Day Moving Average

After a stumble in the market that brought LH to its low price for the period of the last 52 weeks, Laboratory Corporation of America Holdings was able to take a rebound, for now settling with 3.47% of profit for the given period.

The stock volatility was left at 1.73%, however, within the period of a single month, the volatility rate increased by 1.96%, while the shares surge at the distance of +9.26% for the moving average in the last 20 days. In oppose to the moving average for the last 50 days, trading by +12.82% upper at the present time.

In the course of the last 5 trading sessions, LH went up by +5.90%, which changed the moving average for the period of 200 days to the total of +21.77% of gains for the stock in comparison to the 20-day moving average settled at $181.35. In addition, Laboratory Corporation of America Holdings saw 15.11% in overturn over the period of a single year with a tendency to cut further gains.

LH Stock Insider Trading

Reports are indicating that there were more than several insider trading activities at Laboratory Corporation of America Holdings (LH), starting from Schroeder Mark S, who sold 108 shares at the price of $181.99 back on Feb 10. After this action, Rushing now owns 300 shares of Laboratory Corporation of America Holdings, valued at $19,655 with the latest closing price.

van der Vaart Sandra D, the SVP, Global General Counsel of Laboratory Corporation of America Holdings, sold 133 shares at the value of $181.99 during a trade that took place back on Feb 10, which means that van der Vaart Sandra D is holding 2,529 shares at the value of $24,205 based on the most recent closing price.

LH Stock Fundamentals

The current profitability levels are settled at +12.12 for the present operating margin and +25.98 for gross margin. The net margin for Laboratory Corporation of America Holdings stands at +7.80. Total capital return value is set at 10.30, while invested capital returns managed to touch 6.75. Equity return holds the value 10.60%, with 4.40% for asset returns.

Based on Laboratory Corporation of America Holdings (LH), the company’s capital structure generated 86.92 points for debt to equity in total, while total debt to capital is set at the value of 46.50. Total debt to assets is settled at the value of 37.44 with long-term debt to equity ratio rests at 5.63 and long-term debt to capital is 86.67.

The value for Enterprise to Sales is 1.99 with debt to enterprise value settled at 0.33. The receivables turnover for Laboratory Corporation of America Holdings is 6.33 with the total asset turnover at the value of 0.69. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.51.